Hercules Capital Key Executives
This section highlights Hercules Capital's key executives, including their titles and compensation details.
Find Contacts at Hercules Capital
(Showing 0 of )
Hercules Capital Earnings
This section highlights Hercules Capital's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-13 | $0.51 | $0.49 |
| Read Transcript | Q3 | 2024 | 2024-10-30 | $0.51 | $0.51 |
| Read Transcript | Q2 | 2024 | 2024-08-01 | $0.51 | $0.51 |
| Read Transcript | Q1 | 2024 | 2024-05-02 | $0.50 | $0.50 |
| Read Transcript | Q4 | 2023 | 2024-02-15 | $0.50 | $0.56 |
| Read Transcript | Q3 | 2023 | 2023-11-02 | $0.50 | $0.52 |
| Read Transcript | Q2 | 2023 | 2023-08-03 | $0.49 | $0.53 |
| Read Transcript | Q1 | 2023 | 2023-05-04 | $0.46 | $0.47 |
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million to $250 million in equity per transactions. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; San Diego, California; Westport, Connecticut; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia and London, United Kingdom.
$17.54
Stock Price
$3.04B
Market Cap
50
Employees
Palo Alto, CA
Location
Financial Statements
Access annual & quarterly financial statements for Hercules Capital, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $415.93M | $460.67M | $184.64M | $255.13M | $297.77M |
| Cost of Revenue | $54.23M | $1.60M | $43.85M | $36.97M | $29.00M |
| Gross Profit | $361.69M | $459.07M | $140.79M | $218.16M | $268.78M |
| Gross Profit Ratio | 86.96% | 99.65% | 76.25% | 85.51% | 90.26% |
| Research and Development Expenses | $- | $- | $0 | $1 | $1 |
| General and Administrative Expenses | $19.67M | $18.70M | $16.95M | $16.11M | $18.91M |
| Selling and Marketing Expenses | $- | $54.40M | $- | $- | $- |
| Selling General and Administrative Expenses | $19.67M | $73.09M | $16.95M | $16.11M | $18.91M |
| Other Expenses | $104.63M | $- | $65.61M | $64.87M | $51.60M |
| Operating Expenses | $124.31M | $73.09M | $82.56M | $80.98M | $70.51M |
| Cost and Expenses | $178.54M | $73.09M | $141.94M | $80.98M | $70.51M |
| Interest Income | $467.19M | $434.43M | $307.26M | $253.36M | $263.38M |
| Interest Expense | $77.15M | $67.62M | $54.75M | $54.45M | $59.60M |
| Depreciation and Amortization | $466.00K | $190.00K | $163.93M | $73.25M | $-55.71M |
| EBITDA | $- | $405.29M | $250.62M | $213.39M | $224.43M |
| EBITDA Ratio | 0.00% | 87.98% | 135.74% | 83.64% | 75.37% |
| Operating Income | $237.39M | $387.57M | $272.93M | $174.16M | $227.26M |
| Operating Income Ratio | 57.07% | 84.13% | 147.82% | 68.26% | 76.32% |
| Total Other Income Expenses Net | $25.58M | $-50.09M | $-153.75M | $-46.84M | $-1.04M |
| Income Before Tax | $262.97M | $337.48M | $102.08M | $174.16M | $227.26M |
| Income Before Tax Ratio | 63.22% | 73.26% | 55.29% | 68.26% | 76.32% |
| Income Tax Expense | $- | $- | $-54.75M | $-58.87M | $-59.60M |
| Net Income | $262.97M | $337.48M | $156.83M | $174.16M | $227.26M |
| Net Income Ratio | 63.22% | 73.26% | 84.94% | 68.26% | 76.32% |
| EPS | $1.63 | $2.32 | $1.25 | $1.50 | $2.02 |
| EPS Diluted | $1.63 | $2.31 | $1.24 | $1.49 | $2.01 |
| Weighted Average Shares Outstanding | 161.08M | 144.09M | 125.19M | 114.74M | 111.98M |
| Weighted Average Shares Outstanding Diluted | 161.60M | 144.83M | 126.66M | 115.95M | 112.27M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47.93M | $119.05M | $119.22M | $129.72M | $139.35M | $51.49M | $118.12M | $117.53M | $84.67M | $72.93M | $8.97M | $18.07M | $26.40M | $42.58M | $100.84M | $83.61M | $169.15M | $59.87M | $78.97M | $73.62M |
| Cost of Revenue | $37.05M | $12.16M | $2.44M | $2.58M | $37.42M | $2.58M | $12.84M | $2.37M | $-15.52M | $10.97M | $-63.15M | $8.33M | $2.02M | $8.90M | $8.35M | $9.80M | $- | $7.18M | $7.18M | $92.05M |
| Gross Profit | $10.88M | $106.89M | $116.78M | $127.14M | $101.94M | $48.91M | $105.28M | $115.16M | $100.19M | $61.96M | $72.11M | $9.74M | $24.38M | $33.69M | $92.49M | $73.81M | $169.15M | $52.68M | $71.79M | $-18.43M |
| Gross Profit Ratio | 22.71% | 89.79% | 97.95% | 98.01% | 73.15% | 94.98% | 89.13% | 97.98% | 118.33% | 84.96% | 804.14% | 53.91% | 92.33% | 79.10% | 91.72% | 88.27% | 100.00% | 88.00% | 90.91% | -25.03% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $5.54M | $4.60M | $4.48M | $5.06M | $4.83M | $4.59M | $5.15M | $4.13M | $4.44M | $4.36M | $4.32M | $3.82M | $4.36M | $4.08M | $4.07M | $3.60M | $4.72M | $4.30M | $4.96M | $4.92M |
| Selling and Marketing Expenses | $- | $- | $18.66M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $5.54M | $4.60M | $4.48M | $5.06M | $4.83M | $4.59M | $5.15M | $4.13M | $4.44M | $4.36M | $4.32M | $3.82M | $4.36M | $4.08M | $4.07M | $3.60M | $4.72M | $4.30M | $4.96M | $4.92M |
| Other Expenses | $12.31M | $27.54M | $26.61M | $-18.55M | $34.05M | $-67.18M | $24.95M | $18.84M | $17.69M | $15.36M | $19.67M | $17.59M | $20.03M | $14.95M | $14.04M | $15.85M | $13.26M | $12.52M | $12.24M | $13.58M |
| Operating Expenses | $17.85M | $32.14M | $23.49M | $18.55M | $19.18M | $23.52M | $23.35M | $22.97M | $22.13M | $19.73M | $19.29M | $21.41M | $22.69M | $19.04M | $18.11M | $19.45M | $17.98M | $16.82M | $17.21M | $18.51M |
| Cost and Expenses | $54.90M | $44.30M | $58.21M | $21.13M | $76.30M | $23.52M | $42.95M | $22.97M | $6.61M | $36.09M | $68.24M | $21.41M | $24.39M | $33.44M | $33.80M | $35.13M | $17.98M | $31.62M | $32.28M | $33.04M |
| Interest Income | $114.84M | $119.05M | $117.53M | $115.78M | $115.20M | $110.34M | $108.99M | $99.90M | $94.87M | $81.41M | $68.73M | $62.25M | $64.96M | $63.31M | $61.31M | $63.78M | $68.25M | $65.38M | $63.55M | $66.20M |
| Interest Expense | $20.00M | $20.37M | $19.16M | $17.62M | $17.38M | $16.43M | $17.18M | $16.62M | $15.90M | $14.50M | $12.70M | $11.65M | $12.14M | $13.07M | $14.49M | $14.75M | $15.19M | $14.81M | $15.08M | $14.53M |
| Depreciation and Amortization | $-373.00K | $91.00K | $96.00K | $186.00K | $23.00K | $59.00K | $64.00K | $44.00K | $44.00K | $50.00K | $56.00K | $54.00K | $62.00K | $68.00K | $93.00K | $94.00K | $96.00K | $97.00K | $96.00K | $126.00K |
| EBITDA | $-466.00K | $89.17M | $103.96M | $99.37M | $- | $44.45M | $95.41M | $84.50M | $- | $67.75M | $54.38M | $12.05M | $18.63M | $38.39M | $- | $- | $59.45M | $43.14M | $- | $- |
| EBITDA Ratio | -0.97% | 74.90% | 87.20% | 76.60% | 0.00% | 86.34% | 80.77% | 71.89% | 0.00% | 92.90% | 606.34% | 66.68% | 70.56% | 90.15% | 0.00% | 0.00% | 35.15% | 72.07% | 0.00% | 0.00% |
| Operating Income | $-6.97M | $74.75M | $61.01M | $108.59M | $63.50M | $27.97M | $66.04M | $111.19M | $- | $136.99M | $54.32M | $8.31M | $15.85M | $29.87M | $27.51M | $28.65M | $166.36M | $33.75M | $31.27M | $33.16M |
| Operating Income Ratio | -14.54% | 62.79% | 51.18% | 83.71% | 45.56% | 54.32% | 55.91% | 94.60% | 0.00% | 187.84% | 605.72% | 45.99% | 60.04% | 70.15% | 27.28% | 34.27% | 98.35% | 56.38% | 39.60% | 45.05% |
| Total Other Income Expenses Net | $-194.56M | $-6.04M | $-63.77M | $-8.93M | $56.68M | $-69.66M | $28.73M | $8.72M | $62.53M | $-15.08M | $-43.99M | $-15.39M | $-53.09M | $-14.77M | $27.31M | $10.62M | $90.56M | $-13.29M | $- | $-61.89M |
| Income Before Tax | $-201.53M | $68.71M | $41.85M | $90.96M | $120.18M | $27.97M | $94.78M | $94.56M | $62.53M | $53.20M | $-10.32M | $-3.34M | $3.71M | $23.55M | $82.73M | $64.16M | $151.17M | $43.05M | $61.77M | $-28.72M |
| Income Before Tax Ratio | -420.44% | 57.72% | 35.10% | 70.12% | 86.24% | 54.32% | 80.23% | 80.46% | 73.86% | 72.95% | -115.05% | -18.46% | 14.06% | 55.30% | 82.05% | 76.74% | 89.37% | 71.91% | 78.21% | -39.02% |
| Income Tax Expense | $-1.70M | $- | $737.00K | $958.00K | $-16.56M | $-16.43M | $-64.00K | $16.62M | $- | $-14.50M | $- | $11.65M | $12.14M | $6.75M | $69.71M | $50.26M | $- | $24.10M | $45.57M | $-47.36M |
| Net Income | $-200.85M | $68.03M | $41.85M | $90.96M | $120.18M | $27.97M | $94.78M | $94.56M | $62.53M | $53.20M | $-10.32M | $-14.98M | $3.71M | $23.55M | $82.73M | $64.16M | $151.17M | $43.05M | $61.77M | $-28.72M |
| Net Income Ratio | -419.02% | 57.14% | 35.10% | 70.12% | 86.24% | 54.32% | 80.23% | 80.46% | 73.86% | 72.95% | -115.05% | -82.90% | 14.06% | 55.30% | 82.05% | 76.74% | 89.37% | 71.91% | 78.21% | -39.02% |
| EPS | $-1.21 | $0.42 | $0.26 | $0.57 | $0.76 | $0.19 | $0.66 | $0.69 | $0.48 | $0.42 | $-0.08 | $-0.13 | $0.03 | $0.20 | $0.71 | $0.56 | $1.32 | $0.38 | $0.55 | $-0.27 |
| EPS Diluted | $-1.21 | $0.42 | $0.25 | $0.57 | $0.76 | $0.19 | $0.66 | $0.68 | $0.47 | $0.41 | $-0.08 | $-0.13 | $0.03 | $0.20 | $0.65 | $0.55 | $1.31 | $0.38 | $0.55 | $-0.26 |
| Weighted Average Shares Outstanding | 165.07M | 161.02M | 160.75M | 157.44M | 157.76M | 146.90M | 141.39M | 135.25M | 130.56M | 127.48M | 124.25M | 118.30M | 115.19M | 114.81M | 114.65M | 114.30M | 113.90M | 113.49M | 111.56M | 107.64M |
| Weighted Average Shares Outstanding Diluted | 165.61M | 161.51M | 161.31M | 157.92M | 157.76M | 147.11M | 142.08M | 137.06M | 132.28M | 129.33M | 124.25M | 118.30M | 116.75M | 116.24M | 129.57M | 114.80M | 114.26M | 113.74M | 111.73M | 108.95M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $42.68M | $98.90M | $15.80M | $133.12M | $198.28M |
| Short Term Investments | $- | $- | $2.89B | $- | $- |
| Cash and Short Term Investments | $42.68M | $98.90M | $2.90B | $133.12M | $198.28M |
| Net Receivables | $32.58M | $32.74M | $31.68M | $17.36M | $19.08M |
| Inventory | $- | $- | $1 | $1 | $256.70M |
| Other Current Assets | $- | $- | $- | $- | $- |
| Total Current Assets | $75.26M | $131.64M | $2.93B | $150.48M | $217.36M |
| Property Plant Equipment Net | $16.78M | $4.79M | $4.99M | $6.76M | $9.28M |
| Goodwill | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $-3.03B | $-158.73M | $-260.64M |
| Long Term Investments | $- | $3.25B | $2.96B | $2.43B | $2.35B |
| Tax Assets | $- | $- | $3.03B | $2.60B | $2.62B |
| Other Non-Current Assets | $- | $- | $-2.96B | $-2.44B | $-2.36B |
| Total Non-Current Assets | $16.78M | $3.25B | $4.99M | $2.44B | $2.36B |
| Other Assets | $3.74B | $32.45M | $88.89M | $8.25M | $43.28M |
| Total Assets | $3.83B | $3.42B | $3.03B | $2.60B | $2.62B |
| Account Payables | $54.86M | $50.79M | $47.54M | $42.08M | $36.34M |
| Short Term Debt | $18.19M | $104.83M | $- | $379.30M | $27.90M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $- | $40.40M | $-201.15M |
| Other Current Liabilities | $-73.06M | $1.89M | $-42.03M | $-414.00M | $173.24M |
| Total Current Liabilities | $73.06M | $157.51M | $5.51M | $47.78M | $36.34M |
| Long Term Debt | $- | $1.45B | $1.58B | $4.42M | $6.41M |
| Deferred Revenue Non-Current | $- | $- | $1.63B | $1.29B | $1.33B |
| Deferred Tax Liabilities Non-Current | $- | $- | $2.91M | $4.42M | $6.41M |
| Other Non-Current Liabilities | $1.82B | $- | $39.12M | $1.28B | $1.09B |
| Total Non-Current Liabilities | $1.82B | $1.45B | $1.62B | $1.24B | $1.30B |
| Other Liabilities | $-54.86M | $3.37M | $- | $- | $- |
| Total Liabilities | $1.84B | $1.61B | $1.63B | $1.29B | $1.33B |
| Preferred Stock | $- | $- | $67.79M | $149.07M | $97.40M |
| Common Stock | $170.75M | $158.00K | $134.00K | $117.00K | $115.00K |
| Retained Earnings | $- | $140.01M | $59.91M | $216.52M | $133.39M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $-67.79M | $67.45M | $35.99M |
| Other Total Stockholders Equity | $1.82B | $1.66B | $1.34B | $1.09B | $1.19B |
| Total Stockholders Equity | $1.99B | $1.80B | $1.40B | $1.31B | $1.29B |
| Total Equity | $1.99B | $1.80B | $2.96B | $2.42B | $2.35B |
| Total Liabilities and Stockholders Equity | $3.83B | $3.42B | $3.03B | $2.60B | $2.62B |
| Minority Interest | $- | $- | $1.55B | $1.11B | $1.06B |
| Total Liabilities and Total Equity | $3.83B | $3.42B | $3.03B | $2.60B | $2.62B |
| Total Investments | $3.66B | $3.25B | $2.96B | $2.43B | $2.35B |
| Total Debt | $18.19M | $1.56B | $1.58B | $1.24B | $1.30B |
| Net Debt | $-24.48M | $1.46B | $1.56B | $1.11B | $1.10B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $42.68M | $38.90M | $38.92M | $60.29M | $98.90M | $31.98M | $61.70M | $71.13M | $15.80M | $57.06M | $115.31M | $59.33M | $133.12M | $235.85M | $18.45M | $74.99M | $198.28M | $27.55M | $35.88M | $34.28M |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $2.75B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $42.68M | $38.90M | $38.92M | $60.29M | $98.90M | $31.98M | $61.70M | $71.13M | $15.80M | $2.80B | $115.31M | $59.33M | $133.12M | $235.85M | $18.45M | $74.99M | $198.28M | $27.55M | $35.88M | $34.28M |
| Net Receivables | $32.58M | $31.45M | $31.53M | $35.40M | $32.74M | $32.05M | $32.09M | $31.48M | $31.68M | $25.49M | $22.11M | $19.65M | $17.36M | $17.86M | $19.06M | $20.60M | $19.08M | $19.51M | $19.46M | $19.14M |
| Inventory | $- | $- | $- | $1 | $148.75M | $1 | $106.12M | $110.43M | $- | $90.91M | $- | $82.11M | $1 | $267.22M | $43.28M | $1 | $-58.48M | $1 | $-33.60M | $-22.06M |
| Other Current Assets | $- | $- | $- | $15.13M | $- | $5.25M | $- | $7.82M | $-31.68M | $- | $3.37M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Current Assets | $75.26M | $70.35M | $59.21M | $95.69M | $131.64M | $64.03M | $93.78M | $102.61M | $15.80M | $2.83B | $140.79M | $78.98M | $150.48M | $253.71M | $37.51M | $95.58M | $198.28M | $47.06M | $55.34M | $53.42M |
| Property Plant Equipment Net | $16.78M | $17.25M | $18.10M | $18.58M | $4.79M | $5.06M | $3.78M | $4.35M | $4.99M | $5.67M | $6.35M | $6.14M | $6.76M | $7.37M | $8.04M | $8.67M | $9.28M | $9.88M | $10.49M | $11.08M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $3.56B | $3.57B | $3.57B | $3.25B | $3.26B | $3.11B | $3.13B | $2.96B | $2.83B | $2.72B | $2.59B | $2.43B | $2.51B | $2.52B | $2.46B | $2.35B | $2.42B | $2.36B | $2.30B |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $- | $-3.56B | $-3.57B | $10.13M | $-3.25B | $-3.27B | $-3.11B | $-3.13B | $-2.97B | $-2.83B | $3.69M | $-2.60B | $-2.44B | $-2.51B | $-2.52B | $-2.46B | $-2.35B | $-2.42B | $-2.36B | $-2.30B |
| Total Non-Current Assets | $16.78M | $17.25M | $18.10M | $3.60B | $4.79M | $3.27B | $3.78M | $3.13B | $3.01B | $5.67M | $2.73B | $2.60B | $2.44B | $7.37M | $8.04M | $8.67M | $9.28M | $9.88M | $10.49M | $11.08M |
| Other Assets | $3.74B | $3.57B | $3.59B | $- | $3.28B | $5.92M | $3.13B | $14.68M | $3.03B | $90.88M | $- | $14.09M | $8.25M | $2.53B | $2.53B | $2.48B | $2.42B | $2.45B | $2.40B | $2.33B |
| Total Assets | $3.83B | $3.66B | $3.67B | $3.70B | $3.42B | $3.34B | $3.22B | $3.25B | $3.03B | $2.92B | $2.87B | $2.69B | $2.60B | $2.79B | $2.58B | $2.58B | $2.62B | $2.50B | $2.47B | $2.40B |
| Account Payables | $54.86M | $46.86M | $49.52M | $35.16M | $54.16M | $44.06M | $46.50M | $31.87M | $47.54M | $34.49M | $34.71M | $20.23M | $42.08M | $37.10M | $36.89M | $28.30M | $36.34M | $28.78M | $29.16M | $22.45M |
| Short Term Debt | $18.19M | $- | $- | $3.61M | $1.89M | $105.12M | $2.02M | $3.79M | $- | $652.00K | $8.54M | $9.25M | $379.30M | $587.00K | $1.78M | $2.33M | $- | $573.00K | $1.68M | $2.25M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $- | $- | $-49.52M | $- | $- | $45.89M | $- | $31.47M | $- | $- | $-1.88M | $20.35M | $40.40M | $- | $- | $- | $- | $- | $- | $- |
| Other Current Liabilities | $-73.06M | $- | $106.00M | $-38.77M | $-50.85M | $-149.18M | $-44.64M | $-35.66M | $-47.54M | $-29.05M | $-36.59M | $-22.60M | $-421.38M | $-29.81M | $-30.86M | $-21.77M | $201.15M | $208.18M | $206.73M | $- |
| Total Current Liabilities | $73.06M | $46.86M | $18.95M | $38.70M | $5.20M | $46.26M | $3.89M | $33.37M | $- | $6.09M | $38.59M | $27.23M | $47.78M | $7.88M | $7.81M | $8.86M | $237.49M | $237.54M | $237.57M | $238.15M |
| Long Term Debt | $- | $17.88M | $- | $17.60M | $1.45B | $4.98M | $1.59B | $3.07M | $- | $1.53B | $- | $4.50M | $- | $1.42B | $1.18B | $1.24B | $6.41M | $9.18M | $1.27B | $1.20B |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $1.82B | $-17.88M | $1.66B | $-17.60M | $- | $-4.98M | $-981.00K | $-3.07M | $- | $- | $- | $1.35B | $- | $- | $- | $- | $1.09B | $1.08B | $-206.73M | $-142.33M |
| Total Non-Current Liabilities | $1.82B | $1.80B | $1.80B | $1.77B | $1.61B | $1.64B | $1.64B | $33.37M | $- | $1.56B | $1.50B | $1.33B | $47.78M | $1.45B | $1.21B | $1.26B | $1.09B | $1.09B | $1.07B | $1.06B |
| Other Liabilities | $-54.86M | $-46.26M | $- | $- | $- | $- | $- | $1.69B | $1.63B | $- | $- | $- | $1.20B | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $1.84B | $1.80B | $1.82B | $1.81B | $1.61B | $1.68B | $1.64B | $1.75B | $1.63B | $1.56B | $1.54B | $1.36B | $1.29B | $1.45B | $1.22B | $1.27B | $1.33B | $1.33B | $1.30B | $1.30B |
| Preferred Stock | $- | $- | $- | $1 | $- | $- | $- | $1 | $- | $- | $1 | $- | $- | $- | $- | $- | $0 | $0 | $- | $- |
| Common Stock | $170.75M | $163.00K | $163.00K | $163.00K | $158.00K | $152.00K | $145.00K | $139.00K | $134.00K | $131.00K | $128.00K | $124.00K | $117.00K | $116.00K | $116.00K | $116.00K | $115.00K | $115.00K | $115.00K | $111.00K |
| Retained Earnings | $- | $109.67M | $118.90M | $154.95M | $140.01M | $72.53M | $117.09M | $89.70M | $59.91M | $74.25M | $84.99M | $155.31M | $216.52M | $170.69M | $192.33M | $154.76M | $133.39M | $-52.86M | $-59.35M | $-85.11M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $0 | $6.23M | $0 | $0 | $0 | $- | $0 | $0 | $0 | $67.45M | $0 | $-0 | $1.16B | $-0 | $-0 | $0 | $-0 |
| Other Total Stockholders Equity | $1.82B | $1.74B | $1.74B | $1.73B | $1.66B | $1.58B | $1.47B | $1.41B | $1.34B | $1.29B | $1.24B | $1.18B | $1.09B | $1.17B | $1.16B | $1.16B | $1.16B | $1.23B | $1.22B | $1.18B |
| Total Stockholders Equity | $1.99B | $1.85B | $1.86B | $1.89B | $1.80B | $1.65B | $1.59B | $1.50B | $1.40B | $1.36B | $1.33B | $1.33B | $1.31B | $1.34B | $1.36B | $1.32B | $1.29B | $1.17B | $1.16B | $1.10B |
| Total Equity | $1.99B | $1.85B | $1.86B | $1.89B | $1.80B | $1.65B | $1.59B | $1.50B | $1.40B | $1.36B | $1.33B | $1.33B | $1.31B | $1.34B | $1.36B | $1.32B | $1.29B | $1.17B | $1.16B | $1.10B |
| Total Liabilities and Stockholders Equity | $3.83B | $3.66B | $3.67B | $3.70B | $3.42B | $3.34B | $3.22B | $3.25B | $3.03B | $2.92B | $2.87B | $2.69B | $2.60B | $2.79B | $2.58B | $2.58B | $2.62B | $2.50B | $2.47B | $2.40B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $3.83B | $3.66B | $3.67B | $3.70B | $3.42B | $3.34B | $3.22B | $3.25B | $3.03B | $2.92B | $2.87B | $2.69B | $2.60B | $2.79B | $2.58B | $2.58B | $2.62B | $2.50B | $2.47B | $2.40B |
| Total Investments | $3.66B | $3.56B | $3.57B | $3.57B | $3.25B | $3.26B | $3.11B | $3.13B | $2.96B | $2.83B | $2.72B | $2.59B | $2.43B | $2.51B | $2.52B | $2.46B | $2.35B | $2.42B | $2.36B | $2.30B |
| Total Debt | $18.19M | $18.48M | $1.77B | $1.77B | $1.56B | $1.64B | $1.59B | $1.72B | $- | $1.53B | $1.51B | $1.33B | $1.24B | $1.42B | $1.19B | $1.24B | $1.30B | $1.30B | $1.28B | $1.28B |
| Net Debt | $-24.48M | $-20.42M | $1.73B | $1.71B | $1.46B | $1.61B | $1.53B | $1.65B | $-15.80M | $1.47B | $1.39B | $1.27B | $1.11B | $1.18B | $1.17B | $1.17B | $1.10B | $1.27B | $1.24B | $1.24B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $31.49M | $337.48M | $102.08M | $174.16M | $227.26M |
| Depreciation and Amortization | $31.21M | $190.00K | $204.00K | $317.00K | $415.00K |
| Deferred Income Tax | $- | $- | $- | $-10.38M | $-8.47M |
| Stock Based Compensation | $12.48M | $- | $13.38M | $11.93M | $11.05M |
| Change in Working Capital | $- | $-17.17M | $-16.23M | $13.39M | $5.74M |
| Accounts Receivables | $62.00K | $- | $-14.21M | $1.71M | $1.13M |
| Inventory | $- | $- | $- | $- | $-1.13M |
| Accounts Payables | $- | $- | $- | $- | $-16.00K |
| Other Working Capital | $15.36M | $-17.17M | $-2.01M | $11.68M | $5.76M |
| Other Non Cash Items | $-193.27M | $-252.23M | $-521.69M | $-59.25M | $-25.62M |
| Net Cash Provided by Operating Activities | $-118.09M | $68.28M | $-424.80M | $128.62M | $207.80M |
| Investments in Property Plant and Equipment | $- | $-887.00K | $-114.00K | $-106.00K | $-137.00K |
| Acquisitions Net | $- | $- | $- | $106.00K | $137.00K |
| Purchases of Investments | $-1.54B | $- | $-1.47B | $-1.47B | $-761.26M |
| Sales Maturities of Investments | $1.01B | $- | $545.64M | $111.89M | $32.78M |
| Other Investing Activities | $536.62M | $- | $919.39M | $1.36B | $728.48M |
| Net Cash Used for Investing Activities | $-705.00K | $-887.00K | $-114.00K | $-106.00K | $-137.00K |
| Debt Repayment | $213.63M | $-24.00M | $343.04M | $-62.17M | $-2.93M |
| Common Stock Issued | $220.88M | $344.35M | $232.09M | $10.83M | $77.18M |
| Common Stock Repurchased | $-3.43M | $-12.70M | $-4.53M | $-2.82M | $-1.84M |
| Dividends Paid | $-303.48M | $-273.68M | $-245.12M | $-175.50M | $-152.42M |
| Other Financing Activities | $-8.40M | $-11.22M | $-10.95M | $-209.00K | $-5.33M |
| Net Cash Used Provided by Financing Activities | $119.20M | $22.75M | $314.52M | $-229.87M | $-85.04M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- |
| Net Change in Cash | $408.00K | $90.14M | $-110.39M | $-101.36M | $122.63M |
| Cash at End of Period | $116.42M | $116.01M | $25.88M | $136.26M | $237.62M |
| Cash at Beginning of Period | $116.01M | $25.88M | $136.26M | $237.62M | $115.00M |
| Operating Cash Flow | $-118.09M | $68.28M | $-424.80M | $128.62M | $207.80M |
| Capital Expenditure | $- | $-887.00K | $-114.00K | $-106.00K | $-137.00K |
| Free Cash Flow | $-118.09M | $67.39M | $-424.91M | $128.51M | $207.66M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-167.67M | $68.71M | $41.12M | $90.01M | $120.18M | $27.97M | $94.78M | $94.56M | $62.53M | $53.20M | $-10.32M | $-3.34M | $3.71M | $23.55M | $82.73M | $64.16M | $151.17M | $43.05M | $61.77M | $-28.72M |
| Depreciation and Amortization | $-13.77M | $44.70M | $96.00K | $186.00K | $23.00K | $59.00K | $64.00K | $44.00K | $44.00K | $50.00K | $56.00K | $54.00K | $62.00K | $68.00K | $93.00K | $94.00K | $96.00K | $97.00K | $96.00K | $126.00K |
| Deferred Income Tax | $- | $- | $- | $- | $-27.36M | $-3.34M | $-3.33M | $-3.19M | $- | $- | $- | $-3.12M | $47.62M | $- | $- | $-164.73M | $68.15M | $- | $-56.04M | $18.20M |
| Stock Based Compensation | $- | $2.80M | $3.34M | $3.13M | $3.39M | $3.34M | $3.33M | $3.19M | $- | $2.47M | $3.66M | $4.42M | $2.94M | $3.32M | $2.93M | $2.74M | $3.58M | $2.52M | $2.13M | $2.08M |
| Change in Working Capital | $605.00K | $-6.91M | $13.83M | $-6.91M | $-21.92M | $169.00K | $15.49M | $-10.91M | $7.87M | $-7.17M | $19.67M | $-36.59M | $10.48M | $1.88M | $9.20M | $-8.17M | $10.20M | $-1.31M | $8.14M | $-11.28M |
| Accounts Receivables | $-1.19M | $69.00K | $3.87M | $-2.74M | $-684.00K | $27.00K | $-594.00K | $201.00K | $-6.17M | $-3.27M | $-2.48M | $-2.29M | $494.00K | $1.20M | $1.53M | $-1.52M | $-749.00K | $-48.00K | $-321.00K | $1.07M |
| Inventory | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-16.00K |
| Other Working Capital | $1.80M | $-6.98M | $9.96M | $-4.17M | $-21.23M | $142.00K | $16.09M | $-11.11M | $14.04M | $-3.90M | $22.15M | $-34.30M | $9.98M | $678.00K | $7.67M | $-6.65M | $10.95M | $-1.26M | $8.46M | $-12.33M |
| Other Non Cash Items | $-164.74M | $-30.32M | $24.95M | $-15.32M | $48.03M | $-143.56M | $23.31M | $-164.57M | $-135.36M | $-107.58M | $121.36M | $-148.75M | $27.69M | $15.37M | $-53.79M | $55.71M | $-2.06M | $-53.08M | $-4.15M | $-5.10M |
| Net Cash Provided by Operating Activities | $-345.57M | $78.98M | $83.66M | $64.84M | $130.88M | $-115.36M | $133.64M | $-80.87M | $-64.92M | $-53.17M | $-118.08M | $-188.62M | $99.94M | $40.87M | $38.23M | $-50.42M | $231.82M | $-11.25M | $11.93M | $-24.70M |
| Investments in Property Plant and Equipment | $- | $670.00K | $-378.00K | $-292.00K | $-497.00K | $-11.00K | $-285.00K | $-94.00K | $-28.00K | $-12.00K | $-24.00K | $-50.00K | $-94.00K | $- | $- | $-12.00K | $-22.00K | $-48.00K | $-38.00K | $-29.00K |
| Acquisitions Net | $- | $- | $- | $- | $887.00K | $- | $- | $- | $- | $- | $- | $50.00K | $106.00K | $- | $- | $12.00K | $137.00K | $- | $- | $29.00K |
| Purchases of Investments | $-362.38M | $-224.98M | $-349.86M | $-605.24M | $-1.60B | $-456.87M | $-358.60M | $-476.16M | $- | $-1.10B | $-439.11M | $-351.60M | $-1.47B | $-404.04M | $-273.81M | $-355.33M | $-761.26M | $- | $- | $-233.61M |
| Sales Maturities of Investments | $259.75M | $120.17M | $325.69M | $299.50M | $1.05B | $267.97M | $403.19M | $343.28M | $- | $392.41M | $268.52M | $8.82M | $111.89M | $-225.15M | $898.76M | $12.97M | $32.78M | $- | $- | $17.08M |
| Other Investing Activities | $432.52M | $104.10M | $- | $418.82M | $552.06M | $188.90M | $-44.59M | $132.88M | $- | $705.40M | $- | $342.79M | $1.36B | $- | $- | $342.36M | $728.34M | $- | $- | $216.54M |
| Net Cash Used for Investing Activities | $329.89M | $-30.00K | $-24.54M | $-306.03M | $-497.00K | $-11.00K | $-285.00K | $-94.00K | $-28.00K | $-12.00K | $-24.00K | $-50.00K | $-94.00K | $-45.00K | $-4.20M | $-12.00K | $-22.00K | $-48.00K | $-38.00K | $-29.00K |
| Debt Repayment | $-181.00M | $-9.00M | $-6.00M | $196.00M | $-79.00M | $43.00M | $-127.00M | $139.00M | $52.00M | $21.18M | $175.36M | $94.50M | $-177.64M | $233.86M | $-56.42M | $-55.51M | $-6.50M | $26.24M | $-1.13M | $-21.54M |
| Common Stock Issued | $153.60M | $- | $- | $67.28M | $100.74M | $111.28M | $66.16M | $66.17M | $40.08M | $43.29M | $62.54M | $86.18M | $10.83M | $- | $- | $-195.00K | $3.61M | $- | $38.89M | $34.96M |
| Common Stock Repurchased | $-1.03M | $-1.09M | $1.40M | $-2.70M | $-577.00K | $-512.00K | $-10.23M | $-1.38M | $206.00K | $-572.00K | $-894.00K | $-3.27M | $-710.00K | $-744.00K | $-323.00K | $-1.04M | $-270.00K | $-389.00K | $-283.00K | $-895.00K |
| Dividends Paid | $-225.59M | $-75.50M | $-75.84M | $-74.25M | $-71.93M | $-71.48M | $-66.44M | $-63.83M | $-66.19M | $-63.00M | $-59.07M | $-56.86M | $-45.41M | $-44.24M | $-44.09M | $-41.76M | $-38.03M | $-35.63M | $-35.36M | $-43.40M |
| Other Financing Activities | $355.68M | $-1.84M | $-36.00K | $-867.00K | $-833.00K | $-3.72M | $-751.00K | $-5.92M | $-680.00K | $-976.00K | $-3.60M | $-5.69M | $-1.00K | $-4.59M | $-3.00K | $-2.07M | $-1.04M | $-346.00K | $-881.00K | $-3.05M |
| Net Cash Used Provided by Financing Activities | $101.65M | $-87.43M | $-80.48M | $185.46M | $-51.60M | $78.57M | $-138.27M | $134.04M | $25.41M | $-83.00K | $174.33M | $114.86M | $-212.94M | $184.28M | $-100.84M | $-100.38M | $-42.23M | $-10.13M | $1.25M | $-33.92M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $72.40M | $5.10M | $-21.37M | $-55.73M | $78.78M | $-36.80M | $-4.91M | $53.07M | $-39.53M | $-53.27M | $56.22M | $-73.81M | $-113.09M | $225.15M | $-62.60M | $-150.81M | $189.56M | $-21.42M | $13.14M | $-58.65M |
| Cash at End of Period | $116.42M | $44.02M | $38.92M | $60.29M | $116.01M | $37.23M | $74.03M | $78.95M | $25.88M | $65.41M | $118.68M | $62.46M | $136.26M | $249.36M | $24.21M | $86.82M | $237.62M | $48.06M | $69.48M | $56.34M |
| Cash at Beginning of Period | $44.02M | $38.92M | $60.29M | $116.01M | $37.23M | $74.03M | $78.95M | $25.88M | $65.41M | $118.68M | $62.46M | $136.26M | $249.36M | $24.21M | $86.82M | $237.62M | $48.06M | $69.48M | $56.34M | $115.00M |
| Operating Cash Flow | $-345.57M | $78.98M | $83.66M | $64.84M | $130.88M | $-115.36M | $133.64M | $-80.87M | $-64.92M | $-53.17M | $-118.08M | $-188.62M | $99.94M | $40.87M | $38.23M | $-50.42M | $231.82M | $-11.25M | $11.93M | $-24.70M |
| Capital Expenditure | $700.00K | $-30.00K | $-378.00K | $-292.00K | $-497.00K | $-11.00K | $-285.00K | $-94.00K | $-28.00K | $-12.00K | $-24.00K | $-50.00K | $-94.00K | $- | $- | $-12.00K | $-22.00K | $-48.00K | $-38.00K | $-29.00K |
| Free Cash Flow | $-344.87M | $92.53M | $83.28M | $64.55M | $130.38M | $-115.38M | $133.35M | $-80.97M | $-64.95M | $-53.19M | $-118.11M | $-188.67M | $99.85M | $40.87M | $38.23M | $-50.43M | $231.79M | $-11.29M | $11.90M | $-24.73M |
Hercules Capital Dividends
Explore Hercules Capital's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
9.38%
Dividend Payout Ratio
115.40%
Dividend Paid & Capex Coverage Ratio
-0.39x
Hercules Capital Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.47 | $0.47 | February 26, 2025 | February 26, 2025 | March 05, 2025 | February 11, 2025 |
| $0.48 | $0.48 | November 13, 2024 | November 13, 2024 | November 20, 2024 | October 28, 2024 |
| $0.48 | $0.48 | August 13, 2024 | August 13, 2024 | August 20, 2024 | July 30, 2024 |
| $0.48 | $0.48 | May 13, 2024 | May 14, 2024 | May 21, 2024 | April 30, 2024 |
| $0.48 | $0.48 | February 27, 2024 | February 28, 2024 | March 06, 2024 | February 13, 2024 |
| $0.48 | $0.48 | November 14, 2023 | November 15, 2023 | November 22, 2023 | October 31, 2023 |
| $0.48 | $0.48 | August 17, 2023 | August 18, 2023 | August 25, 2023 | August 01, 2023 |
| $0.47 | $0.47 | May 15, 2023 | May 16, 2023 | May 23, 2023 | May 02, 2023 |
| $0.47 | $0.47 | March 01, 2023 | March 02, 2023 | March 09, 2023 | February 14, 2023 |
| $0.51 | $0.51 | November 09, 2022 | November 10, 2022 | November 17, 2022 | October 18, 2022 |
| $0.5 | $0.5 | August 08, 2022 | August 09, 2022 | August 16, 2022 | July 26, 2022 |
| $0.48 | $0.48 | May 16, 2022 | May 17, 2022 | May 24, 2022 | May 03, 2022 |
| $0.48 | $0.48 | March 08, 2022 | March 09, 2022 | March 16, 2022 | February 22, 2022 |
| $0.4 | $0.4 | November 09, 2021 | November 10, 2021 | November 17, 2021 | October 26, 2021 |
| $0.39 | $0.39 | August 10, 2021 | August 11, 2021 | August 18, 2021 | July 27, 2021 |
| $0.39 | $0.39 | May 11, 2021 | May 12, 2021 | May 19, 2021 | April 27, 2021 |
| $0.37 | $0.37 | March 05, 2021 | March 08, 2021 | March 15, 2021 | February 22, 2021 |
| $0.34 | $0.34 | November 06, 2020 | November 09, 2020 | November 16, 2020 | October 27, 2020 |
| $0.32 | $0.32 | August 07, 2020 | August 10, 2020 | August 17, 2020 | July 29, 2020 |
| $0.32 | $0.32 | May 13, 2020 | May 14, 2020 | May 21, 2020 | May 01, 2020 |
Hercules Capital News
Read the latest news about Hercules Capital, including recent articles, headlines, and updates.
Hercules Capital Announces Date for Release of First Quarter 2025 Financial Results and Conference Call
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2025 financial results conference call for Thursday, May 1, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial.
Correction: Hercules Capital Receives Secured Debt Rating Upgrade to BBB from Fitch Ratings, Inc.
SAN MATEO, Calif.--(BUSINESS WIRE)--This press release corrects, replaces and entirely supersedes a prior version published on April 16, 2025. Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has upgraded Hercules' senior s.
Hercules Capital Receives Investment Grade Rating Upgrade to BBB from Fitch Ratings, Inc.
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has upgraded Hercules' investment grade credit and corporate rating to BBB from BBB- with a stable outlook, as well as its underlying anal.
Hercules Capital: You Can Lock In A 10% Yield Again
Market volatility due to new tariffs has created a buying window for high-quality BDCs like Hercules Capital, offering a 10% dividend yield. Hercules Capital's strong performance in 2024, with record gross fundings and growing portfolio, positions it well for future growth in the VC-backed tech sector. Despite being the most expensive BDC, Hercules Capital's solid dividend coverage, supplemental dividends, and growth catalysts justify its high NAV premium.
BDC Weekly Review: BDCs Plunge On Macro Fears
We take a look at the action in business development companies through the first week of April and highlight some of the key themes we are watching. BDCs faced significant losses, with average returns around -9% on the week with valuations dropping below historical averages. Valuation uncertainty is high due to quarterly NAV declarations and systemic/idiosyncratic factors; estimated NAV drops are 2-3% from Q4 levels.
MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates
Zug, Switzerland, April 3, 2025 – MoonLake Immunotherapeutics (MoonLake; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has entered into an agreement with Hercules Capital, Inc. (NYSE:HTGC), a leader in customized debt financing for companies in the life sciences and technology-related markets, for up to $500 million in non-dilutive capital, of which $75 million drawn down at close and additional tranches will become available upon achievement of certain pre-specified milestones that are aligned with MoonLake's strategy and funding needs.
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has entered into a loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), for up to $200 million. Access to the additional capital strengthens Savara's balance sheet following the submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a tre.
Hercules Capital: It Can't Be Missing From Any Dividend Portfolio
Hercules Capital is one of the best BDC with a 20-year history, offering a 10.4% dividend yield and a +1,040% total return since inception. HTGC's strong financials, including recent record-high TII and NII, ensure sustainable dividends and long-term stability. The recent 19% pullbacks give a decent buy signal, despite the stock's premium P/NAV valuation.
Is It Worth Investing in Hercules Capital (HTGC) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Hercules Capital: Buy The Drop On This Income Machine
Hercules Capital offers a compelling buy-the-dip opportunity for income investors with a 10% dividend yield and strong earnings yield. HTGC's internally managed structure enhances shareholder alignment and cost efficiency, supporting consistently high returns and a high-quality, predominantly first-lien portfolio. Despite recent market volatility, HTGC maintains low non-accrual rates, strong dividend coverage, conservative leverage, and robust liquidity.
Forget Growth: 5 Big Safe Yields Worth Considering
The stock market has been ugly (particularly growth stocks), and it could get much worse. Thankfully, however, there is another way. Income investing focuses on big, steady dividend and interest payments, thereby allowing investors to worry far less about price volatility (as long as those big income payments keep coming in). This report shares 5 big safe yield strategies (including a variety of top income ideas), and then concludes with an important takeaway about succeeding in this market.
2 Income ETFs To Ride Out The Current Market Decline
Dividends provide stability and psychological benefits during market declines, helping investors avoid panic selling and irrational decisions. Janus Henderson AAA CLO ETF offers a 6.1% dividend yield with investment-grade debt, providing stable income and sector diversification. Putnam BDC Income ETF offers a 9.1% dividend yield with high-quality BDCs, combining capital appreciation and income, but with higher price volatility.
Hercules Capital Receives Investment Grade Rating Upgrade to BBB (high) with Revised Outlook to Stable from Morningstar DBRS
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Morningstar DBRS (“DBRS”) has upgraded Hercules' investment grade credit and corporate rating to BBB (high) from BBB with a trend revision from Positive to Stable, as w.
KBRA Assigns Rating to Hercules Capital, Inc.'s $250 Million Convertible Unsecured Notes Due 2028
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns a rating of BBB+ to Hercules Capital, Inc.'s (NYSE: HTGC or “the company”) $250 million 4.75% convertible unsecured notes due September 2028. The rating Outlook is Stable. Key Credit Considerations The rating reflects the company's diversified $3.66 billion investment portfolio consisting of 118 portfolio companies (debt investments) with a focus on senior secured first lien venture debt investments (86.9%) in the technology and life sciences sectors, sol.
Hercules Capital: Secure A Juicy 9% Yield On The Drop
Hercules Capital achieved record results in FY 2024, with record gross funding and net investment income, making it a top BDC for dividend consistency reasons. Despite trading at a 74% premium to NAV, the recent market drop presents a new buying opportunity for dividend investors seeking high-quality recurring income. Hercules Capital's focus on technology and life sciences, along with a non-accrual percentage of 0.5%, underscores its exceptional balance sheet quality.
Hercules Capital Prices $250.0 Million of Convertible Unsecured Notes
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has agreed to sell to the initial purchasers in a private offering, $250.0 million aggregate principal amount of its 4.75% Convertible Unsecured Notes due 2028 (the “Convertible Notes”). The Company also has granted the initial purchasers an option to purchase up to an additional $37.5 million principal amount of the Convertible Notes to cover overallotments, if any. Th.
Hercules Capital Announces Offering of $250.0 Million of Convertible Unsecured Notes
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it plans to make an offering of $250.0 million aggregate principal amount of its Convertible Unsecured Notes due 2028 (the “Convertible Notes”). The Company plans to grant the initial purchasers an option to purchase up to an additional $37.5 million principal amount of the Convertible Notes to cover overallotments, if any. The Convertible Notes will be offered only to qua.
BDC Investors Beware: 3 Major Risks You Can't Ignore Right Now
BDCs have been soaring, but cracks are starting to show—here's what investors need to watch out for. We discuss why most BDCs are not worth buying now. One BDC stands out as a strong buy—find out which name offers value, safety, and sustainable dividends.
Buy These 7-11% Yielding Cash Cows For Retirement Income
Capital Southwest offers an 11% yield, strong balance sheet, and robust deal flow, making it a compelling investment in the underserved lower middle market. Omega Healthcare Investors provides a 7.4% yield, steady long-term leases, and improving operator fundamentals, offering growth in supply constrained markets. Both CSWC and OHI present attractive high-yielding opportunities, offering stability and potentially strong returns amidst market volatility and high-growth stock pressures.
BDC Weekly Review: Few Worries About MSDL Share Cap Raise
We take a look at the action in business development companies through the second week of February and highlight some of the key themes we are watching. BDCs saw a strong 2% gain, driven by solid earnings and hot inflation numbers, with CGBD underperforming due to a BOA rating cut. Morgan Stanley Direct Lending Fund seeks shareholder approval to increase shares significantly, a common practice among BDCs with minimal dilution concerns.
I'm Buying Up To 9% Yield For Recurring Income
The 4% rule may be outdated due to current inflation and market conditions, making income stocks all the more relevant. I highlight two quality players who offer well-covered dividends and strong business models. Both companies carry strong balance sheets, and could be potentially rewarding for long-term income and growth.
Hercules Capital: Q4 Results Reinforce Portfolio Strength
Hercules Capital has shown strong portfolio growth, with a 20.63% price increase and a 33.5% total return over the past year. HTGC's portfolio is robust, with 91% first lien senior secured debt and 97.4% floating rate structure, benefiting from the high-interest rate environment. Despite a slight miss in Q4 earnings, HTGC's net investment income and total investment income have grown consistently, supported by new investments.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for HTGC.